We investigate the significance of T-lymphocytes in inflammation and autoimmunity with a special emphasis on metabolic regulation of T cell reactions. We apply a multidisciplinary approach that comprises in vitro studies and in vivo disease models in order to identify new molecular and metabolic pathways that control the pathogenicity of T cells.
The research focus of the lab is on regulating immune responses in the context of autoimmune disease. Special attention is paid to explaining the role of environmental factors such as aging, nutrition and metabolism as well as their interaction in the regulation of autoreactive T cells.
Dendritic cells are present in many organs and tissues and are capable of activating naive T lymphocytes and thus inducing immune responses to microbial and cell antigens. They appear to drive immunity vs. tolerance and exist as multiple functionally relevant subsets. We investigate their development and function in immune homeostasis and disease processes.
T cells is an essential component of human adaptive immunity playing pivotal roles in pathogen recognition, regulation of immune responses, and the maintenance of tolerance toward autoantigens and commensal microbiota. Our research group focuses on unconventional T cells, a subset distinguished by their ability to recognize a broad spectrum of non-peptide antigens, including lipids, small metabolites, drug metabolites, and drug-like molecules. We study non-peptide antigen presentation in the context of cancer, metabolic and autoimmune diseases, and allergy.